Cardioprotective Impact of JAKi, Tofacitinib, on CV Risk in Rheumatoid Arthritis: JAKi CV Risk Impact Study

被引：0
|
作者：
Syngle, Ashit [1 ]
Verma, Inderjeet [2 ]
Garg, Nidhi
Chauhan, Kanchan [1 ]
Patyal, Sapna [1 ]
Syngle, Devaansh [3 ]
机构：
[1] Healing Touch City Clin, Chandigarh, India
[2] Maharishi Markandeshwar Univ, Mulana, India
[3] Healing Touch Fdn, Chandigarh, India
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0448
引用
收藏
页码：868 / 869
页数：2
相关论文
共 50 条
  • [1] IMPACT OF JAKI, TOFACITINIB, ON CV RISK IN RHEUMATOID ARTHRITIS: JAKI CV RISK IMPACT STUDY
    Syngle, A.
    Verma, I.
    Garg, N.
    Chauhan, K.
    Patyal, S.
    Syngle, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 716 - 717
  • [2] Impact of Tofacitinib on Fracture Risk in Rheumatoid Arthritis
    Hansen, Karen E.
    Mortezavi, Mahta
    Nagy, Edward
    Wang, Cunshan
    Connell, Carol A.
    Radi, Zaher
    Litman, Heather J.
    Adami, Giovanni
    Rossini, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2821 - 2824
  • [3] The Impact of Neighborhoods on CV Risk
    Roux, Ana V. Diez
    Mujahid, Mahasin S.
    Hirsch, Jana A.
    Moore, Kari
    Moore, Latetia V.
    GLOBAL HEART, 2016, 11 (03) : 353 - 363
  • [4] Impact of Ethnicity and Menopausal Status on CV Risk Factors
    Strimike, Carolyn
    Latrella, Margie
    JOURNAL OF CARDIOVASCULAR NURSING, 2010, 25 (05) : 359 - 360
  • [5] Prediabetes: lifestyle changes and/or metformin without impact on CV risk?
    Lorenz, Judith
    AKTUELLE KARDIOLOGIE, 2023, 12 (02)
  • [6] Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
    Ytterberg, Steven R.
    Bhatt, Deepak L.
    Mikuls, Ted R.
    Koch, Gary G.
    Fleischmann, Roy
    Rivas, Jose L.
    Germino, Rebecca
    Menon, Sujatha
    Sun, Yanhui
    Wang, Cunshan
    Shapiro, Andrea B.
    Kanik, Keith S.
    Connell, Carol A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 316 - 326
  • [7] Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
    Ozdede, Ayse
    Yazici, Hasan
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1766 - 1766
  • [8] Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study
    Tuccori, Marco
    Lorenzoni, Valentina
    Gini, Rosa
    Turchetti, Giuseppe
    Fini, Elisabetta
    Giometto, Sabrina
    Bartolini, Claudia
    Paoletti, Olga
    Convertino, Irma
    Ferraro, Sara
    Cappello, Emiliano
    Valdiserra, Giulia
    Blandizzi, Corrado
    Lucenteforte, Ersilia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 392 - 392
  • [9] MUSCULOSKELETAL ULTRASOUND IN MONITORING RESPONSE TO JAKI IN RHEUMATOID ARTHRITIS PATIENTS: RESULTS FROM A LONGITUDINAL STUDY
    Cipriano, E.
    Ceccarelli, F.
    Spinelli, F. R.
    Garufi, C.
    Duca, I.
    Mancuso, S.
    Alessandri, C.
    Di Franco, M.
    Priori, R.
    Riccieri, V.
    Scrivo, R.
    Perricone, C.
    Valesini, G.
    Conti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1231 - 1232
  • [10] AMELIORATION OF ENDOTHELIAL DYSFUNCTION WITH JAK INHIBITION IN RHEUMATOID ARTHRITIS: JAK CV-RISK REDUCTION STUDY
    Syngle, A.
    Garg, N.
    Chauhan, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 318 - 319
12345